Early Career Awards

At each EUROTOX Congress, one or two awards will be made to early career scientist(s) judged to have made the best oral or poster presentation. No more than one EUROTOX Early Career Award will be made in each category. In addition, up to two runners-up in each class may be designated ‘highly commended’, depending on quality and at the discretion of the panel of judges. The first and presenting author must be under 35 years of age as of 31 December of the year of the EUROTOX Congress.

Evaluation criteria

The contributions will be evaluated by a panel consisting of Chairs of the Speciality Sections, chaired by the SPC Chair. The final choice of the winner(s) will be based on evaluation of the presentations based on the following criteria:

  • Originality and potential impact of the research project
  • Adequacy of the methodological approach adopted
  • Scientific value of the results
  • Care, quality and clarity of the poster

2023 Award Recipients

Award winners were announced during the closing ceremony of EUROTOX2023 in Ljubljana, and presented with a certificate and the respective award prize.

EUROTOX Gerhard-Zbinden Award for drug-oriented toxicological research

Linda Steinacher
F. Hoffmann-La Roche AG, Pharma Research and Early Development, Switzerland
Advanced pulmonary in vitro models to investigate immune related toxicities.

ECETOC CHRISTA HENNES Award for toxicological research into mechanisms and risk assessment

Martina Iulini
Università degli Studi di Milano, Pharmacological and Biomolecular Sciences, Italy
In vitro study of the effect of PFAS on the antibody production


Highly Commended Recognition

Tamara Danilyuk
Leiden University, Drug Discovery & Safety, The Netherlands
Human-induced pluripotent stem cell reporters for high-content screening of stress response activation identifying target organ-specific toxicities.

ALFONSO LOSTIA Award for food safety research

Nicole Pinckaers
Maastricht University, Pharmacology and Toxicology, The Netherlands
Quantitative in vitro-to-in vivo extrapolation of adrenergic potencies of phenethylamines detected in sport nutrition supplements using physiologically based kinetic modeling-based reverse dosimetry.